71 related articles for article (PubMed ID: 9219608)
1. Z1046: a new specific peripheral dopaminergic compound.
Ferlenga P; Zanzottera D; Biasini I; Marchini F; Semeraro C
Acta Physiol Hung; 1996; 84(3):283-4. PubMed ID: 9219608
[TBL] [Abstract][Full Text] [Related]
2. Z1046: biochemical characterization of its dopaminergic activity.
Fantoni M; Moriggi E; Bisiani C; Masotto C; Pocchiari F; Semeraro C
Acta Physiol Hung; 1996; 84(3):279-80. PubMed ID: 9219606
[TBL] [Abstract][Full Text] [Related]
3. Direct vasodilating effects of the new dopaminergic agonist Z1046 in human arteries.
Teisman AC; Buikema H; van Veldhuisen DJ; de Zeeuw D; van Gilst WH
J Cardiovasc Pharmacol; 2000 Apr; 35(4):581-5. PubMed ID: 10774789
[TBL] [Abstract][Full Text] [Related]
4. Effects of dopamine receptor agonists on the cAMP content in arteries of the rabbit.
Zhu L; Zhao RR; Zhang WF
Sheng Li Xue Bao; 2000 Jun; 52(3):247-51. PubMed ID: 11956574
[TBL] [Abstract][Full Text] [Related]
5. [Effects of dopexamine on cardiac hemodynamics during myocardial ischemia in rats and in comparison with fenoldopam and procaterol].
Qin F; Zhang W; Zhao R; Chen J
Yao Xue Xue Bao; 1998; 33(2):106-10. PubMed ID: 11938944
[TBL] [Abstract][Full Text] [Related]
6. Comparison of dopexamine hydrochloride, fenoldopam, and procaterol on myocardial nutritional flow in rats.
Qin FZ; Gao Z; Zhao RR
Zhongguo Yao Li Xue Bao; 1994 Sep; 15(5):416-8. PubMed ID: 7717065
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological evidence for the presence of a peripheral postjunctional D2-like dopamine receptor in rabbit splenic artery.
Zanzottera D; Ferlenga P; Marchini F; Semeraro C
Br J Pharmacol; 1998 Feb; 123(4):730-6. PubMed ID: 9517393
[TBL] [Abstract][Full Text] [Related]
8. Amygdaloid D1 receptors are not linked to stimulation of adenylate cyclase.
Leonard SK; Anderson CM; Lachowicz JE; Schulz DW; Kilts CD; Mailman RB
Synapse; 2003 Dec; 50(4):320-33. PubMed ID: 14556237
[TBL] [Abstract][Full Text] [Related]
9. Dopamine: pharmacologic and therapeutic aspects.
Velasco M; Luchsinger A
Am J Ther; 1998 Jan; 5(1):37-43. PubMed ID: 10099036
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and pharmacological evaluation of potent and highly selective D3 receptor ligands: inhibition of cocaine-seeking behavior and the role of dopamine D3/D2 receptors.
Campiani G; Butini S; Trotta F; Fattorusso C; Catalanotti B; Aiello F; Gemma S; Nacci V; Novellino E; Stark JA; Cagnotto A; Fumagalli E; Carnovali F; Cervo L; Mennini T
J Med Chem; 2003 Aug; 46(18):3822-39. PubMed ID: 12930145
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the effects of central and peripheral dopamine receptor activation on evoked firing in the trigeminocervical complex.
Charbit AR; Akerman S; Goadsby PJ
J Pharmacol Exp Ther; 2009 Nov; 331(2):752-63. PubMed ID: 19657051
[TBL] [Abstract][Full Text] [Related]
12. Behavioral effects of cocaine: interactions with D1 dopaminergic antagonists and agonists in mice and squirrel monkeys.
Katz JL; Kopajtic TA; Myers KA; Mitkus RJ; Chider M
J Pharmacol Exp Ther; 1999 Oct; 291(1):265-79. PubMed ID: 10490913
[TBL] [Abstract][Full Text] [Related]
13. Fenoldopam--but not dopamine--selectively increases gastric mucosal oxygenation in dogs.
Schwarte LA; Picker O; Schindler AW; Fournell A; Scheeren TW
Crit Care Med; 2003 Jul; 31(7):1999-2005. PubMed ID: 12847395
[TBL] [Abstract][Full Text] [Related]
14. The role of dopaminergic agonists in congestive heart failure.
Semeraro C; Marchini F; Ferlenga P; Masotto C; Morazzoni G; Pradella L; Pocchiari F
Clin Exp Hypertens; 1997; 19(1-2):201-15. PubMed ID: 9028647
[TBL] [Abstract][Full Text] [Related]
15. [The regulating effects of dopamine receptors on the level of adenosine 3, 5-cyclic monophosphate in bovine trabecular cells in vitro].
Lu Y; Li M
Zhonghua Yan Ke Za Zhi; 1998 Sep; 34(5):379-81. PubMed ID: 11877232
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular actions of the dopamine receptor agonist Z1046 in swine.
Duncker DJ; van Meegen JR; Verdouw PD
Cardiovasc Drugs Ther; 1997 Sep; 11(4):537-45. PubMed ID: 9358958
[TBL] [Abstract][Full Text] [Related]
17. Drug discrimination in methamphetamine-trained monkeys: agonist and antagonist effects of dopaminergic drugs.
Tidey JW; Bergman J
J Pharmacol Exp Ther; 1998 Jun; 285(3):1163-74. PubMed ID: 9618419
[TBL] [Abstract][Full Text] [Related]
18. The role of dopamine in a model of trigeminovascular nociception.
Akerman S; Goadsby PJ
J Pharmacol Exp Ther; 2005 Jul; 314(1):162-9. PubMed ID: 15778266
[TBL] [Abstract][Full Text] [Related]
19. Effects of selective dopaminergic receptor stimulation on ventricular remodeling after experimental myocardial infarction in rats.
Teisman AC; van Veldhuisen DJ; Scholtens E; Maselbas W; van Gilst WH
J Card Fail; 1997 Sep; 3(3):199-205. PubMed ID: 9330128
[TBL] [Abstract][Full Text] [Related]
20. [Effects of l-stepholidine on the peripheral vascular dopamine DA1 and DA2 receptor subtypes].
Zhang W; Zhi J; Guo W; Zhao R; Jin G
Yao Xue Xue Bao; 1998 Oct; 33(10):721-6. PubMed ID: 12016922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
